SCHEMBL5730887

SCHEMBL5730887

Cc1cc(-c2ccccc2)nc2sc3c(OCC4CC4)nc(N4CCNCC4)nc3c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.42
▸ KMT2A Q03164 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ PRKCI P41743 2/20 0.41
▸ HRH3 Q9Y5N1 1/20 0.39
▸ KHK P50053 5/20 0.38
▸ TRIM58 Q8NG06 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ UBE2N P61088 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ GABRA3 P34903 1/20 0.35
▸ GABRA2 P47869 1/20 0.35
▸ CHRM4 P08173 2/20 0.35
▸ P2RY12 Q9H244 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2614860 0.90 HTR2C (0.44) HTR2CKMT2AATMPRKCIKHK
SCHEMBL1321222 0.88 HTR2C (0.43) HTR2CKMT2AATMPRKCIKHK
SCHEMBL1320860 0.88 HTR2C (0.43) HTR2CKMT2AATMPRKCIKHK
SCHEMBL1321171 0.86 HTR2C (0.42) HTR2CKMT2AATMPRKCIKHK
SCHEMBL5730454 0.86 PRKCI (0.46) HTR2CKMT2AATMPRKCIKHK
SCHEMBL1321736 0.84 PRKCI (0.43) HTR2CKMT2AATMPRKCIKHK
Hydrochloric Acid SCHEMBL5731014 0.83 PRKCI (0.42) HTR2CKMT2AATMPRKCIKHK
SCHEMBL1322258 0.82 PRKCI (0.43) HTR2CKMT2AATMPRKCIKHK
SCHEMBL5730893 0.82 HRH3 (0.39) KMT2APRKCIHRH3TRIM58KDM4E
SCHEMBL1322483 0.81 KMT2A (0.42) HTR2CKMT2AATMPRKCIKHK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1619196-A1 Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and Pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of PDA-4 and/or TNF-alpha release Curacyte Discovery GmbH (DE) 2006-01-25 — — EP disclosed
Send feedback